{"id":"W4382799116","doi":"10.1016/j.annonc.2023.04.022","title":"O-7 Adjuvant nivolumab vs placebo in resected esophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: First report of comprehensive biomarker analyses from CheckMate 577","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"LEO Pharma; Ipsen; Astellas Pharma; Servier; Daiichi-Sankyo; Mirati Therapeutics; Merck KGaA; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Internal medicine; Hazard ratio; Oncology; Esophageal cancer; Placebo; Microsatellite instability; Chemoradiotherapy; Cancer; Biomarker; Gastroenterology; Confidence interval; Pathology; Immunotherapy; Gene; Allele","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007842485,0.0003787153,0.001262778,0.0001794797,0.0001771849,0.0007154237,0.0002164481,0.0004332976,0.001084443],"category_scores_gemma":[0.0009856743,0.0001875067,0.001168293,0.0001914939,0.0002822041,0.0005201411,0.0002629571,0.0008851688,0.000220849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005050152,"about_ca_system_score_gemma":0.0006049824,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006812003,"about_ca_topic_score_gemma":0.00237858,"domain_scores_codex":[0.9996867,0.0001196918,0.00002392703,0.00006413925,0.00003325356,0.00007228419],"domain_scores_gemma":[0.9995616,0.0001596661,0.00009393512,0.00005830657,0.000030893,0.00009559408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7667353,0.005488629,0.05736324,0.0007794169,0.004472815,0.0001687481,0.0001413837,0.001070311,0.01846439,0.0001339355,0.002092814,0.143089],"study_design_scores_gemma":[0.08891635,0.3779874,0.488998,0.0004994054,0.01313968,0.0005619125,0.0004571786,0.003848578,0.01482522,0.0007841835,0.009867912,0.0001142411],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951864,0.003634404,0.00009569188,0.0001158188,0.00009046785,0.00006586329,0.000279952,0.00001624333,0.0005152157],"genre_scores_gemma":[0.9968087,0.001309577,0.0002011213,0.00023574,0.00007360022,0.00007602132,0.0007138991,0.000005907807,0.0005754537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001262778,"threshold_uncertainty_score":0.00414753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1963617919623994,"score_gpt":0.4788410146094649,"score_spread":0.2824792226470655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}